Chinese and western medicine treatment of myocardial fibrosis drugs
Frontiers in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 15, 2025
Myocardial
fibrosis
(MF)
is
a
common
pathological
manifestation
of
many
cardiovascular
diseases,
such
as
myocardial
infarction,
ischemia,
and
sudden
cardiac
death.
It
characterized
by
excessive
proliferation
activation
fibroblasts,
transformation
into
myofibroblasts,
and,
eventually,
deposition
the
extracellular
matrix,
resulting
in
heart
damage.
Currently,
modern
drugs
angiotensin-converting
enzyme
inhibitors,
diuretics,
β-blockers
can
improve
clinical
treatment,
but
their
therapeutic
effect
on
this
disease
limited,
with
obvious
side
effects
high
cost.
Traditional
Chinese
medicine
(TCM)
has
advantages
multiple
targets,
low
cost,
few
effects.
medicines,
Salvia
miltiorrhiza,
Astragalus,
Angelica
extracts,
patent
Qiliqiangxin
capsules,
Shenqi
Yiqi
dropping
pills,
Tongxinluo
fibrosis.
In
review,
current
Western
methods
for
treating
are
discussed.
The
signaling
pathways
targets
involved
treatment
This
review
aimed
to
provide
valuable
insights
ideas
both
basic
research
Language: Английский
Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis
Xiaohui Meng,
No information about this author
Sheng Li,
No information about this author
Yongqing You
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 23, 2025
Background
Peritoneal
fibrosis
(PF)
causes
peritoneal
dialysis
(PD)
withdrawal
due
to
ultrafiltration
failure.
Qixue
Huazheng
formula
(QXHZF),
comprising
Astragalus
membranaceus
,
Centella
asiatica
and
Ligusticum
sinense
is
applied
treat
PD-related
peritoneum
injury
related;
however,
the
active
components,
core
genes,
underlying
mechanism
involved
remain
unclear.
Methods
The
anti-PF
effects
of
QXHZF
were
verified
in
vivo
vitro
.
Targets
QXHZF-mediated
improvement
PD-induced
PF
predicted
using
network
pharmacology
analysis.
Metabolites
associated
with
treatment
analyzed
by
serum
metabolomics.
Integration
metabolomics
findings
identified
potentially
important
pathways,
metabolites,
targets,
molecular
docking
studies
confirmed
interactions
key
components
targets.
Western
blotting
(WB),
quantitative
real-time
PCR
(qRT-PCR),
TdT-mediated
dUTP
Nick-End
Labeling
(TUNEL)
staining,
flow
cytometry
conducted.
Results
had
potent
therapeutic
efficacy
against
according
WB,
qRT-PCR,
pathological
section
examination.
Network
pharmacological
analysis
indicated
that
multiple
compounds
contributed
improving
modulating
various
targets
pathways.
Differential
metabolites
Integrated
data
steroid
hormone
biosynthesis,
Ras
signaling
pathway,
apoptosis,
estrogen
QXHZF.
Metabolite-target
analyses
revealed
can
bind
receptor
1
(ESR1)
rapidly
accelerated
fibrosarcoma
(RAF1)
through
its
components.
WB
demonstrated
reversed
activation
above-mentioned
thereby
inhibiting
PD
fluid-induced
PF.
Conclusion
significantly
ameliorate
may
regulate
signaling,
apoptosis
this
context.
Language: Английский
Astragaloside IV as a promising therapeutic agent for liver diseases: current landscape and future perspectives
Chunyan Chen,
No information about this author
Xuexian Bu,
No information about this author
Liping Deng
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 23, 2025
Astragaloside
IV
(C41H68O14,
AS-IV)
is
a
naturally
occurring
saponin
isolated
from
the
root
of
Astragalus
membranaceus,
widely
used
traditional
Chinese
botanical
drug
in
medicine.
In
recent
years,
AS-IV
has
attracted
considerable
attention
for
its
hepatoprotective
properties,
which
are
attributed
to
low
toxicity
as
well
anti-inflammatory,
antioxidant
and
antitumour
effects.
Numerous
preclinical
studies
have
demonstrated
potential
prevention
treatment
various
liver
diseases,
including
multifactorial
injury,
metabolic-associated
fatty
disease,
fibrosis
cancer.
Given
promising
growing
interest
research,
this
review
provides
comprehensive
summary
current
state
research
on
effects
AS-IV,
based
literature
available
databases
such
CNKI,
PubMed,
ScienceDirect,
Google
Scholar
Web
Science.
The
mechanisms
multifaceted,
encompassing
inhibition
inflammatory
responses,
reduction
oxidative
stress,
improvement
insulin
leptin
resistance,
modulation
gut
microbiota,
suppression
hepatocellular
carcinoma
cell
proliferation
induction
tumour
apoptosis.
Notably,
key
molecular
pathways
involved
these
include
Nrf2/HO-1,
NF-κB,
NLRP3/Caspase-1,
JNK/c-Jun/AP-1,
PPARα/FSP1
Akt/GSK-3β/β-catenin.
Toxicity
indicate
that
high
level
safety.
addition,
discusses
sources,
physicochemical
challenges
development
clinical
application
providing
valuable
insights
into
agent
pharmaceutical
nutraceutical
industries.
Language: Английский
Exosomes from renal cells and macrophages: Bidirectional communication in the pathogenesis of kidney disease
Cytokine,
Journal Year:
2025,
Volume and Issue:
192, P. 156961 - 156961
Published: May 17, 2025
Language: Английский
BuyangHuanwu Decoction alleviates Endothelial Cell Apoptosis and Coronary Microvascular Dysfunction via Regulation of the MAPKK4/p38 Signaling Axis
Xing Chang,
No information about this author
Dan Wu,
No information about this author
Xin Gao
No information about this author
et al.
International Journal of Medical Sciences,
Journal Year:
2024,
Volume and Issue:
21(13), P. 2464 - 2479
Published: Jan. 1, 2024
MAPKK4
has
been
implicated
in
the
pathological
mechanisms
underlying
myocardial
and
vascular
injury,
specifically
influencing
endothelial
cell
damage
programmed
death
via
subcellular
pathways.
Nevertheless,
regulatory
role
of
coronary
microvascular
injury
following
infarction
remains
unconfirmed,
exploration
targeted
mitochondrial
protective
therapeutic
agents
unaddressed.
In
light
this
gap,
we
established
a
gene-modified
mouse
model
ischemia-reperfusion
employed
Buyang
Huanwu
decoction
(BYHW),
traditional
cardiovascular
formula,
to
assess
its
efficacy
treating
post-ischemia-reperfusion.
The
study
aimed
elucidate
mechanism
by
which
BYHW
mitigates
induced
through
attenuation
apoptosis.
Experimental
outcomes
revealed
that
high-dose
significantly
ameliorated
post-ischemia-reperfusion,
restoring
structural
integrity
microvasculature
reducing
inflammation
oxidative
stress.
Contrarily,
transgenic
mice
overexpressing
MAPKK4,
intervention
failed
attenuate
To
further
investigate,
simulated
hypoxia/reoxygenation
cells
using
MAPKK4-related
cellular
gene
modification
model.
results
indicated
attenuates
inflammatory
enhances
viability
hypoxic
stress,
inhibiting
apoptosis
pathway.
However,
overexpression
MAPKK4/p38
negated
effects
BYHW,
showing
no
impact
on
stress
under
conditions.
Molecular
interaction
studies
confirmed
active
components
Astragaloside
IV
Ligustrazine,
interact
with
MAPKK4/P38
axis.
Language: Английский
Effect of macrophage‐to‐myofibroblast transition on silicosis
Fei Geng,
No information about this author
Jingrou Xu,
No information about this author
Xichen Ren
No information about this author
et al.
Animal Models and Experimental Medicine,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 9, 2024
Abstract
Background
The
aim
was
to
explore
the
effect
of
macrophage
polarization
and
macrophage‐to‐myofibroblast
transition
(MMT)
in
silicosis.
Methods
Male
Wistar
rats
were
divided
into
a
control
group
silicosis
developed
using
HOPE
MED
8050
dynamic
automatic
dusting
system.
Murine
MH‐S
cells
randomly
an
SiO
2
group.
pathological
changes
lung
tissue
observed
hematoxylin
eosin
(HE)
Van
Gieson
(VG)
staining.
distribution
location
marker
(F4/80),
M1
(iNOS),
M2
(CD206),
myofibroblast
(α‐smooth
muscle
actin
[α‐SMA])
detected
immunohistochemical
immunofluorescent
expression
iNOS,
Arg,
α‐SMA,
vimentin,
type
I
collagen
(Col
I)
measured
Western
blot.
Results
results
HE
VG
staining
showed
obvious
silicon
nodule
formation
thick
fibers
Macrophage
F4/80
increased
gradually
from
8
32
weeks
after
exposure
silica.
Immunohistochemical
revealed
that
there
more
iNOS‐positive
some
CD206‐positive
at
weeks.
More
found
nodules
tissues
blot
analysis
expressions
Inducible
nitric
oxide
synthase
Arg
protein
upregulated
compared
with
those
immunofluorescence
co‐expression
F4/80,
Col
I,
CD206
α‐SMA
co‐expressed
extracted
rat
alveolar
lavage
fluid
+
,
Similar
also
induced
by
.
Conclusions
development
is
accompanied
MMT.
Language: Английский